The safety and tolerability of newer antiepileptic drugs in children and adolescents
- PMID: 20192278
- DOI: 10.2165/11310980-000000000-00000
The safety and tolerability of newer antiepileptic drugs in children and adolescents
Abstract
The newer antiepileptic drugs (AEDs) provide more therapeutic options and overall improved safety and tolerability for patients. To provide the best care, physicians must be familiar with the latest tolerability and safety data. This is particularly true in children, given there are relatively fewer studies examining the effects of AEDs in children compared with adults. Since we now have significant paediatric literature on each of these agents, we provide a comprehensive and current literature review of the newer AEDs, focusing on safety and tolerability data in children and adolescents. Because the safety profiles in children differ from those in adults, familiarity with this literature is important for child neurologists and other paediatric caregivers. We have organized the data by organ system for each AED for easier reference.
Similar articles
-
Safety and tolerability of antiepileptic drug treatment in children with epilepsy.Drug Saf. 2012 Jul 1;35(7):519-33. doi: 10.2165/11630700-000000000-00000. Drug Saf. 2012. PMID: 22702637 Review.
-
The long-term safety of antiepileptic drugs.CNS Drugs. 2013 Jun;27(6):435-55. doi: 10.1007/s40263-013-0063-0. CNS Drugs. 2013. PMID: 23673774 Review.
-
Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: A cross-sectional study.Epilepsy Behav. 2020 Apr;105:106947. doi: 10.1016/j.yebeh.2020.106947. Epub 2020 Feb 25. Epilepsy Behav. 2020. PMID: 32109858
-
Vulnerabilities to antiepileptic drug (AED) side effects in youth with epilepsy.Epilepsy Behav. 2019 Aug;97:22-28. doi: 10.1016/j.yebeh.2019.05.012. Epub 2019 Jun 7. Epilepsy Behav. 2019. PMID: 31181425
-
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.Epilepsy Behav. 2017 Nov;76:24-31. doi: 10.1016/j.yebeh.2017.08.039. Epub 2017 Sep 18. Epilepsy Behav. 2017. PMID: 28931473 Review.
Cited by
-
Design, synthesis, and pharmacological evaluation of [1, 3] dioxolo-chromeno[2,3-b]pyridines as anti-seizure agents.Mol Divers. 2023 Aug;27(4):1809-1827. doi: 10.1007/s11030-022-10538-x. Epub 2022 Oct 10. Mol Divers. 2023. PMID: 36214960
-
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis.CNS Drugs. 2018 Mar;32(3):189-196. doi: 10.1007/s40263-018-0504-x. CNS Drugs. 2018. PMID: 29508243
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical